Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05940272 · ClinicalTrials.gov registry record · NA
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
A NA study of Lymphoma and Lymphoma, B-Cell, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 2
- Study locations
NCT05940272 is a NA study of Lymphoma and Lymphoma, B-Cell that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 48 participants, below the 484-participant average among 299 other Lymphoma trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05940272, a NA study of Lymphoma and Lymphoma, B-Cell, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to develop and test a new communication training intervention called Hematolo-GIST to help oncologists communicate with patients about their lymphoma diagnosis and advance care planning.
Conditions Studied
Interventions
- BEHAVIORAL Hematolo-GIST Training
- BEHAVIORAL Participants Appointment
Study Locations (2)
New York
- Memorial Sloan Kettering Cancer Center (All protocol activities) - New York
- NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only) - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2023-07-03 |
| Est. Completion | 2028-07-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05940272
The ClinicalTrials.gov registry entry for NCT05940272 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 484-participant average among 299 other Lymphoma trials with a reported enrollment target (90% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Lymphoma appearing as the primary indexed condition, and to 2 interventions - of which Hematolo-GIST Training is the first listed.
NCT05940272 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05940272 about?
NCT05940272 is a clinical study titled "Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers". The purpose of this study is to develop and test a new communication training intervention called Hematolo-GIST to help oncologists communicate with patients about their lymphoma diagnosis and advance care planning.
What is the current status of trial NCT05940272?
This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2023-07-03. Estimated completion is 2028-07-03.
What conditions does trial NCT05940272 study?
This clinical trial studies the following conditions: Lymphoma, Lymphoma, B-Cell, Large B-cell Lymphoma, DLBCL - Diffuse Large B Cell Lymphoma, Large-cell Lymphoma.
What interventions are being tested in trial NCT05940272?
The interventions under investigation include: Hematolo-GIST Training (BEHAVIORAL), Participants Appointment (BEHAVIORAL).
Who is sponsoring clinical trial NCT05940272?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05940272 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
RECRUITING · NA
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
RECRUITING · NA
-
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
RECRUITING · NA
-
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation
RECRUITING · NA
-
UPLYFT For Lymphoma Survivors
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.